Genenta Science S.p.A. (GNTA) - Latest Market Data

Price & Market Data

Price: $0.581

Daily Change: -$0.0093 / 1.60%

Daily Range: $0.56 - $0.65

Market Cap: $13,682,791

Daily Volume: 61,247

Performance Metrics

1 Week: -11.97%

1 Month: -12.89%

3 Months: -31.02%

6 Months: -65.55%

1 Year: -85.65%

YTD: -64.54%

About Genenta Science S.p.A. (GNTA)

Get current market data for Genenta Science S.p.A. (GNTA). Price: 0.581, daily change: -$0.0093 / 1.60%. Market cap: 13,682,791. Performance YTD, 1-week, 3-month.

Company Details

Employees: 9

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Italy

Details

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Selected stocks

SOLAI Limited (SLAI)

Bausch Health Companies Inc. (BHC)

Putnam Premier Income Trust (PPT)

Citius Oncology, Inc. (CTOR)